valcyte哪产的？

Valganciclovir Hydrochloride Tablets () is a pharmaceutical preparation developed and produced by Roche. It is suitable for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) and the prevention of CMV infection in high-risk solid organ transplant patients. 

The Roche Group was founded in 1896. Headquartered in Basel, Switzerland, Roche is a world leader in the field of pharmaceuticals and diagnostics. Based on research and development, it aims to provide each patient with a targeted treatment plan through personalized medicine. Roche is committed to its two core businesses - medicines and diagnostics, providing innovative products and services from early detection, prevention, diagnosis to treatment, thereby improving human health and quality of life. Roche is a global leader in in vitro diagnostics, oncology and transplantation medicines; a market leader in virology and other key disease areas such as autoimmune diseases, inflammation, metabolism and central nervous system diseases. Roche is one of the world's leading biotech companies with differentiated medicines in oncology, immunology, anti-infections, ophthalmology and the central nervous system. Roche is a global leader in in vitro diagnostics and tissue-based oncology diagnostics and a pioneer in diabetes management. Since the Roche Group was founded in 1896, Roche has been committed to exploring disease prevention, diagnosis and treatment solutions. Collaborate with relevant stakeholders to improve patient access to innovative medicines. There are 30 medicines developed by Roche on the World Health Organization's Essential Medicines List, including life-saving antibiotics, antimalarials and anti-tumor drugs. Roche has been ranked as the global leader in sustainability in the pharmaceuticals, biotechnology and life sciences sector on the Dow Jones Indices (DJSI) for nine consecutive years.

Valganciclovir hydrochloride tablets () are just one of Roche’s many star products and are good news for patients with CMV retinitis.